The company saw an impressive 56% year-over-year (YOY) boost to revenue, thanks in large part to $12.8 billion in combined sales of its two main GLP-1 agonists, Mounjaro and Zepbound
Without guidance from a registered dietitian, that shift can lead to inadequate protein intake and nutrient gaps and further contribute to muscle loss
Is it the same as the brand name version?", CBC News website , archived from the original on 20 May 2026 "Australian Product Information: Ozempic (semaglutide) solution for injection" (PDF), Therapeutic Goods Administration website , 30 October 2020, archived from the original (PDF) on 8 June 2025 "Assessment report: Ozempic" (PDF), European Medicines Agency website , 11 November 2021, archived from the original (PDF) on 6 February 2025 1 2 "Novo Nordisk CEO flags 1.5 million US users of compounded GLP-1 drugs"
Brands like Ledisa , Kind Patches , and Gentle Patches dominate the market
Massachusetts is keeping coverage for GLP-1 drugs to treat certain other conditions, including diabetes